Remdesivir 100MG/vial INJ
Ended Awarded
- Contract number
- 36C26221N0203
- Awardee
-
Gilead Sciences Inc. UEI FPJMGUK1BYH8
- Awarding agency
-
Veterans Integrated Service Network 22
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $140,130
Award facts
- Contract value 100% obligated
- $140,130.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92161, USA
- National interest action
- Coronavirus COVID-19
Award details come from SAM.gov/FPDS.
About this award
This federal contract award is for the delivery of REMDESIVIR 100MG/VIAL INJ to the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22. The contract was awarded to the prime contractor Gilead Sciences Inc., a for-profit biopharmaceutical manufacturer, on December 3, 2020, with a potential value of $140,130.00. The contract has a completion date of December 11, 2020 and is categorized under the Coronavirus COVID-19 National Interest Action Code. Gilead Sciences Inc. provides pharmaceuticals and biologics to government customers through its General Services Administration (GSA) Multiple Award Schedule (MAS) contract. This order for the antiviral medication remdesivir is being fulfilled directly by Gilead as the prime contractor, with performance occurring at a VA medical facility in San Diego, California.
Quick answers
Who was awarded contract 36C26221N0203?
36C26221N0203 was awarded to Gilead Sciences Inc. by Veterans Integrated Service Network 22 (Veterans Health Administration) on December 3, 2020.
How much is contract 36C26221N0203 worth?
The government has obligated $140,130 on 36C26221N0203.
Is contract 36C26221N0203 an order under another contract?
Yes. 36C26221N0203 is a delivery order under V797D70252, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26221N0203 competed?
The extent of competition for 36C26221N0203 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award